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Objective: Verbal autopsies (VAs) are interviews with a relative or friend of the deceased; VAs are a technique
used in surveillance sites in many countries with incomplete death certification. The goal of this study was to
assess the accuracy and validity of data on HIV status and antiretroviral therapy (ART) usage reported in
VAs and their influence on physician attribution of cause of death.
Design: This was a prospective cohort study.
Methods: The Karonga Health and Demographic Surveillance Site monitors demographic events in a
population in a rural area of northern Malawi; a VA is attempted on all deaths reported. VAs are reviewed by
clinicians, who, with additional HIV test information collected pre-mortem, assign a cause of death. We
linked HIV/ART information reported by respondents during adult VAs to database information on HIV
testing and ART use and analysed agreement using chi-square and kappa statistics. We used multivariable
logistic regression to analyse factors associated with agreement.
Results: From 2003 to 2014, out of a total of 1,952 VAs, 80% of respondents reported the HIV status of the
deceased. In 20132014, this figure was 99%. Of those with an HIV status known to the study, there was 89%
agreement on HIV status between the VA and pre-mortem data, higher for HIV-negative people (92%) than
HIV-positive people (83%). There was 84% agreement on whether the deceased had started ART, and 72% of
ART initiation dates matched within 1 year.
Conclusions: In this population, HIV/ART information was often disclosed during a VA and matched well
with other data sources. Reported HIV/ART status appears to be a reliable source of information to help
classification of cause of death.
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Introduction
The WHO recommends collecting data on HIV/AIDS
history in verbal autopsies (VAs) (1), but there have been
few published studies of validation of HIV status reported
by a proxy after the person has died. VAs are used to
assign likely cause of death (2) for programmatic purposes
in surveillance sites in many low-income settings where
most deaths are not registered or attended by a medical
professional. In some research settings, such as our own,
the VA can provide an additional source of information
on HIVand antiretroviral therapy (ART) in the community
for use in analyses of demography and mortality. The
HIV prevalence in Malawi was estimated to be 10.6% in
2010 (3), and several sites in the country have used VAs
(46).
AVA is an interview with a relative or friend who nursed
the deceased (or was present) during most of their final
illness, with open-ended and structured questions about
signs and symptoms, pre-existing conditions, and treat-
ments. Likely causes of death are assigned by physicians
(7) or computer models (e.g. InterVA or InSilicoVA)
(8). As may be expected, VAs compare well to hospital
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diagnoses (9) but less well with physical autopsies (10).
VAs have been validated to identify HIV/AIDS deaths
using symptoms alone (11), but assigning cause of death
in HIV-positive people is becoming more complex.
Increasingly widespread ART usage and prolonged dura-
tion on treatment is changing the course of the illness and
increasing the range of non-specific symptoms relating to
side-effects and acceleration of degenerative conditions,
which are also seen in HIV-negative people. In addition
to the respondent’s account of the deceased’s illness,
any information from the deceased’s medical records,
including HIV status and use of ART, is considered useful
to physicians when assigning the cause of death; HIV
diagnosis is also a variable used to assign cause of death in
computer models (12). In many settings where VAs are
used, obtaining official medical information/history may
be difficult due to lack of resources to attend clinics and
search through the records, as well as poor record-keeping
(13). In our setting in Malawi, personal health records are
held by the families, though in 2014 the deceased’s health
record was only available in 41% of VAs. Often the only
information available is from the VA respondent.
In many communities, despite rapidly increasing avail-
ability of ART, HIV is still surrounded by stigma (14),
making disclosure of a positive HIV status challenging
(15). Predictors of disclosure do not follow clear trends
(15). People are more likely to disclose a negative status
than a positive one (16) but are more likely to disclose
their positive status to their families when they are ill and
indeed may not have any choice in the matter during a
severe or terminal illness (17). Relatives or friends may
also make assumptions about a person’s HIV status, based
on their appearance, clinic attendance, past perceived
sexual behaviour, or knowledge of the HIV status of a
living or deceased spouse (18). Onward disclosure outside
the family, even after the person has died and during a
confidential interview, may not be socially or culturally
acceptable.
Given these issues, it is important to know whether
HIV/ART information reported in a VA can be relied
upon to assist in assigning likely cause of death, evaluat-
ing ART programme success, and contributing data to
other community-level analyses.
In the Karonga Health and Demographic Surveillance
Site (HDSS) in Malawi, data on HIV status (actual test
records and self-report) and data on use of ART (clinic
records and self-report) can be linked, through personal
identifiers that have been assigned to consenting indivi-
duals, to VA data, which have been systematically collected
since 2003. We compared data from these pre-mortem
sources to estimate the reliability of VA respondent reports
of HIV status and ART usage, as well as their influence on
cause of death assignment.
Methods
Population and data
Population
The Karonga HDSS is well established (19). In brief, a
population of about 39,000 people living in rural villages
in northern Malawi has been under continuous surveil-
lance since 2002. Births and deaths are captured monthly,
and in- and out-migrations annually. The HDSS is run by
the Karonga Prevention Study (KPS), which conducts
many multi-round surveys (including on socio-economic
status and HIV sero-surveys) and evaluates the impact of
interventions (e.g. ART), using the HDSS as a sampling
frame. The Karonga HDSS is a member of the ALPHA
network for analysis of longitudinal, population-based
HIV/AIDS data in Africa (alpha.lshtm.ac.uk) and the
INDEPTH network (indepth-network.org).
VA data
Following the report of a death, a VA is carried out by a
KPS medical assistant, usually between 2 and 6 weeks
after the death. The questionnaire, which has closed and
open-ended questions, has changed over time but is based
on the WHO standard VA questionnaire (1). Since 2003,
respondents have been asked about the presence of disease
symptoms and medical history, including whether the
deceased had ever been diagnosed with HIV/AIDS; in
2009 more detailed questions were added about dates of
HIV testing and ART usage.
Each completed VA questionnaire is reviewed by two
clinicians, who independently assign a likely cause of
death; if they do not agree, a third reviewer (a physician)
makes the decision. A three-level hierarchical system
of coding is used. As it is frequently not possible to
distinguish between AIDS and TB deaths, such deaths are
coded as follows: Level 1 (broad group), communicable
disease; Level 2 (sub-group), AIDS/TB; Level 3 (single
specific categories), one of unspecified, pulmonary TB,
AIDS, or other specific unlisted. The HIV status of
the deceased may be available to the reviewer within the
VA questionnaire (through specific questions or in the free-
text narrative or summary of their medical record) or
through access to the HIV test data (see below).
HIV test data
A household-based adult HIV sero-survey using rapid
tests was carried out in selected clusters in the HDSS
in 20052006, followed by four adult HIV sero-surveys
across the HDSS population from 2007 to 2011. In the first
round, 83% of the population consented to testing, but this
figure decreased to 73% by the fourth round. Rapid tests
were used, and the vast majority of people consented to
be informed of the result. HIV testing with disclosure to
participants has also been offered during other studies
from 1988 onwards. HIV testing is otherwise available
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from several providers in the area (and testing has rapidly
increased during the period covered by this analysis), and
self-reported data on previous test history in any setting
and HIV status (which could be reported as positive,
negative, or unknown) are collected at the time of HIV
testing and in other studies.
ART use data
ART was available at the main hospital (which is 70 km
from the HDSS area) beginning in June 2005, at the rural
hospital within the HDSS area from September 2006
onward, and at smaller clinics in the HDSS area starting
in October 2010. KPS identified and tracked cohorts of
consenting people initiated on ART in all clinics, captur-
ing current and previous ART usage (20).
Socio-economic data
Data on each individual’s schooling and employment
status are collected during annual HDSS surveys. As indi-
cators of socio-economic status, we used the highest educa-
tion level and an employment score based on occupation
and the reliability of the income, where low is the least
skilled and reliable (e.g. piecework) and high is the most
skilled and reliable (e.g. a government worker paid
monthly). The majority of the population are self-employed
subsistence farmers and were classified as medium.
Statistical methods
We restricted the analysis to adults aged 15 years and
over, as HIV test data were only available for this group.
We compared known HIV/ART status and date of ART
initiation (according to test/clinic records or self-report)
with information reported at VA and looked at factors
associated with agreement. We used chi-square tests and
kappa statistics and developed logistic regression models
using forwards stepwise techniques  starting with a basic
model including the deceased’s sex, age, and year of death
and keeping additional variables in the model if a like-
lihood ratio test gave a p-value smaller than 0.1. Available
variables included time between date of death and VA,
place of death, socio-economic status of deceased, type
of respondent, number of HIV tests known to KPS,
number of AIDS signs and symptoms that have been
shown to have moderate to high specificity for predicting
HIV/AIDS deaths in VAs (11) (oral candidiasis, jaundice,
herpes zoster, weight loss, wasting, ulcers/sores, diarrhoea
for more than 1 month or cough for more than 3 weeks),
and HIV and ART status captured by KPS pre-mortem.
We also looked at the correlation between HIV status
reported in the VA and physician coding of deaths as
HIV/AIDS for those without HIV status available in the
KPS database (no negative HIV test within 3 years and no
positive tests). We used Stata 13 for all analyses.
Ethics
Ethical approval was obtained from the National Health
Sciences Research Committee of Malawi (protocols 419,
424, and 448), and the Ethics Committee of the London
School of Hygiene and Tropical Medicine (protocols
5081, 5067, and 5214).
Results
From 2003 to 2014, 2,023 adult (15 years and older) VAs
were conducted. HIV/AIDS diagnosis was asked about in
all but 71 of the VAs (3.5%). Additional questions on
HIV test and ART start dates were added in 2009, so were
only available for 772 (38.2%) VAs; 588 (76.2%) of these
reported a latest HIV test date, and 151 (19.6%) an ART
start date.
VA respondent reporting knowing HIV status
Of 1,952 VA respondents asked, 79.9% (1,560) reported
that they knew the deceased’s HIV status; this proportion
increased over time, from 144/300 (48.0%) in 2003/04 to
299/303 (98.7%) in 2013/14 (Table 1).
In a multivariable analysis, the VA respondent report-
ing that they knew the deceased’s HIV status was
associated with the sex of the deceased (adjusted odds
ratio [aOR] for female vs. male0.7, p0.011), age of the
deceased (aOR for 2029 years vs. 1519 years0.5,
p0.066), year of death (aOR for each increase of
1 year1.3, pB0.001), and number of HIV tests captured
pre-mortem by KPS (aOR for each additional test1.4,
pB0.001) (Table 1).
Agreement on HIV status
There were 959 VAs for which the VA respondent was
asked about the deceased’s HIV status and there was a
linked HIV status (positive, negative, or unknown) cap-
tured by KPS pre-mortem; 993 had no linked pre-mortem
data. According to the VA respondents, 251 of the 959
(26.2%) were HIV positive, while 279/959 (29.1%) were
HIV positive according to pre-mortem data (Table 2).
Overall there was 79.1% agreement (kappa statistic
0.6, pB0.001). In a multivariable analysis of the 959,
agreement was associated with the age of the deceased
(aOR for increase1.2, p0.047), type of respondent
(aOR for partner/sibling/child vs. parent0.3, p0.005
and aOR for other relative vs. parent0.3, p0.004),
number of HIV tests reported to KPS (aOR for increase
1.3, p0.005) and the nature of HIV status reported pre-
mortem to KPS (aOR for positive vs. negative0.6, p0.03
and aOR for unknown vs. negative0.02, pB0.001)
(Table 3).
Excluding those VAs where the informant reported
to KPS that they didn’t know the deceased’s status left
842 people; agreement was then 88.7% (kappa0.5,
pB0.001). Of the 842, 563 were negative in KPS or self-
reported tests, and 515 were also reported negative by the
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Table 1. Characteristics of deceased according to whether respondents reported HIV statusa
HIV status known Univariate
chi-square
Multivariable logistic
regressionb
(n1,952)
Total n % p OR p
Total 1,952 1,560 79.9
Sex 0.012
Male 947 779 82.3 1
Female 1,005 781 77.7 0.7 0.011
Age group (years) B0.001
1519 69 57 82.6 1
2029 213 144 67.6 0.5 0.066
3044 503 358 71.2 0.6 0.23
4559 342 269 78.7 0.9 0.766
6074 369 309 83.7 1.3 0.471
75 456 423 92.8 3.1 0.004
Year of death B0.001 1.3 B0.001
20032004 300 144 48.0
20052006 386 312 80.8
20072008 344 240 69.8
20092010 317 273 86.1
20112012 302 292 96.7
20132014 303 299 98.7
Place of death 0.043 N/A
Home 705 583 82.7
Health facility 1,012 801 79.2
Traditional healer 23 15 65.2
Relative’s house 89 65 73
Other 121 94 77.7
Missingc 2 2 100
Highest schooling B0.001 N/A
None 259 217 83.8
13 years of primary 394 344 87.3
47 years of primary 466 373 80
Primary completed 357 257 72
JCE completed 168 133 79.2
MSCE completed 207 148 71.5
Missingc 101 88 87.1
Rank of employment B0.001 N/A
Low 513 434 84.6
Medium 1,170 929 79.4
High 175 115 65.7
Missingc 96 82 85.4
Type of respondent B0.001 N/A
Parent 286 212 74.1
Partner/sibling/child 1,138 936 82.2
Other relative 485 386 79.6
Non-relative 43 26 60.5
AIDS symptoms 0.001 N/A
One or fewer 1,293 1,061 82.1
Two or more 650 493 75.8
Missingc 9 6 66.7
Latest KPS/self-reported HIV result 0.224 N/A
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respondent (specificity of respondent report91.4%).
Two hundred seventy-nine were HIV positive according
to KPS or self-reported HIV test, and 232 were also
reported positive in the VA (sensitivity of respondent
report83.2%).
Agreement on ART usage
There were 154 VAs on HIV-positive people with informa-
tion on ART usage that could be linked to self-reports
or clinic reports of ART initiation: overall there was
83.8% agreement (kappa statistic0.4, pB0.001). In a
multivariable analysis of the 154, agreement was asso-
ciated with the presence of fewer AIDS symptoms
(aOR for two or more vs. one or fewer0.1, p0.004),
number of HIV tests reported to KPS (aOR for in-
crease1.6, p0.069), and ART usage reported pre-
mortem to KPS (OR for started vs. not31.3, pB0.001)
(Table 4).
Table 1 (Continued )
HIV status known Univariate
chi-square
Multivariable logistic
regressionb
(n1,952)
Total n % p OR p
Negative 563 529 94
Positive 279 257 92.1
Unknown 117 105 89.7
Total number of HIV tests reported to KPS B0.001 1.4 0.001
None 1,156 817 70.7
One to two 479 438 91.4
Three to four 255 244 95.7
Five or more 62 61 98.4
Time between death and interview 0.575 1.01 0.073
Within 6 weeks 1,412 1,119 79.2
6 weeks to 6 months 439 356 81.1
612 months 79 66 83.5
Over 12 months 22 19 86.4
KPS, Karonga Prevention Study; OR, Odds ratio; JCE, Junior Certificate of Education (taken after 2 years of secondary school); MSCE,
Malawi School Certificate of Education (taken after 4 years of secondary school).
aWhere data on HIV status were available from verbal autopsy, n1,952.
bMultivariable logistic regression model included only variables with a result here; all variables included in model as continuous variables
except where OR given for each level.
cRecords with missing values were excluded from the analysis concerning that variable.
Table 2. Comparing HIV status reported to KPS prior to death with HIV status reported by respondent in the VAa
HIV status reported in VA
HIV status reported by deceased to KPS Negative Positive Unknown Total
Negative n 515 14 34 563
(row%) (91.5%) (2.5%) (6%) (100%)
(column%) (58.7%)
Positive n 25 232 22 279
(row%) (9%) (83.2%) (7.9%) (100%)
(column%) (29.1%)
Unknown n 100 5 12 117
(row%) (85.5%) (4.3%) (10.3%) (100%)
(column%) (12.2%)
Total n 640 251 68 959
(row%) (66.7%) (26.2%) (7.1%) (100%)
KPS, Karonga Prevention Study; VA, verbal autopsy.
aWhere data on HIV status were available from both VA and other KPS source, n959.
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Table 3. Characteristics of deceased according to whether HIV status reported by respondent agrees with other information
known to KPSa
VA agree Univariate
chi-square
Multivariable logistic
regressionb (n959)
Total n % p OR p
Total 959 759 79.1
Sex 0.006
Male 485 401 82.7 1
Female 474 358 75.5 1 0.941
Age group (years) B0.001 1.2 0.047
1519 30 25 83.3
2029 100 82 82
3044 231 199 86.1
4559 171 140 81.9
6074 183 142 77.6
75 244 171 70.1
Year of death 0.002 1 0.937
20032004 1 0 0
20052006 36 31 86.1
20072008 97 64 66
20092010 268 208 77.6
20112012 279 223 79.9
20132014 278 233 83.8
Place of death 0.009 N/A
Home 302 220 72.8
Health facility 542 450 83
Traditional healer 12 8 66.7
Relative’s house 40 31 77.5
Other 63 50 79.4
Highest schooling 0.056 N/A
None 127 86 67.7
13 years of primary 183 140 76.5
47 years of primary 221 174 78.7
Primary completed 180 147 81.7
JCE completed 89 72 80.9
MSCE completed 94 77 81.9
Missingc 65 63 96.9
Rank of employment 0.041 N/A
Low 227 165 72.7
Medium 607 488 80.4
High 61 45 73.8
Missingc 64 61 95.3
Type of respondent B0.001
Parent 129 115 89.1 1
Partner/sibling/child 590 471 79.8 0.3 0.005
Other relative 223 158 70.9 0.3 0.004
Non-relative 17 15 88.2 2.7 0.333
AIDS symptoms 0.068 N/A
One or fewer 663 514 77.5
Two or more 295 244 82.7
Missingc 1 1 100
Total number of HIV tests reported to KPS B0.001 1.3 0.005
None 163 58 35.6
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According to clinic reports or self-reports, 28 people
had not started ART, and 13 were also reported as such
in the VA (specificity of respondent report46.4%). In
all, 126 people had started ART; 116 were also reported
as such in the VA (sensitivity of respondent re-
port92.1%). In addition, 31 VAs provided information
on whether the deceased had started ART that could not
be linked to any pre-mortem data source, and 10 were
reported to have started ART.
ART initiation dates reported
An ART initiation date was reported in 151 VAs, of
which 115 (76.2%) could be linked to a clinic or self-
reported start date: 83 (72.2%) of these matched within 1
year, 20 (17.4%) were more than 1 year after, and 12
(10.4%) were more than 1 year before.
Influence of VA HIV status on cause of death
assignment
Of the 1,944 VAs with a likely cause of death assigned (79
[3.9%] did not have enough information to be able to assign
a cause), 594 (30.6%) were coded as HIV/AIDS deaths.
There were 1,559 VAs for which the reviewer had no KPS
data on the deceased’s HIV status (no negative HIV test
within 3 years, and no positive tests), so cause of death
would only be based on information from the VA ques-
tionnaire. In 354 cases there was no HIV status reported
during the VA either, and 148 (41.8%) were coded as HIV/
AIDS. In 225 cases, the respondent reported that the
deceased was HIV positive and the death was coded as
HIV/AIDS in 213 (94.7%), whereas in 980 cases a negative
HIV status was reported and the death was coded as HIV/
AIDS in only 34 (3.5%). This effect was also seen after
stratifying the 1,559 according to whether they had AIDS
symptoms: with one or fewer symptoms, a positive report
from the VA increased the chance of a death to be coded
as HIV/AIDS from 24.9 to 83.9%, and with two or more
symptoms a negative report decreased this chance from
65.1 to 11.0% (Fig. 1).
Discussion
Our study confirms the importance of HIV data reported
by the VA respondent, showing how the respondent’s
report of the deceased’s HIV status influences the way
the physician reviewer assigns cause of death irrespective
of symptoms: a death in a person with a given set of
symptoms consistent with AIDS was much more likely
to be coded as HIV/AIDS when the respondent said
the deceased was HIV positive than when he or she was
reported to be HIV negative or when the status was missing.
HIV results (particularly positive) are also weighted heavily
in computer models (12). VAs have often been shown to
be fairly reliable compared to hospital notes (9), though
a study in Ethiopia found that for HIV/AIDS and TB
diagnoses the sensitivity was high but specificity lower and
a number of false positives could be expected (21). This
influence of VA HIV status on cause of death is likely to be
found in other settings, which may have less complete or
differential reporting of HIV/ART information in VAs, so
it is important to know whether the HIV status reported by
the VA respondent can be relied on.
In our study, the proportion of VA respondents
reporting that they knew the deceased’s HIV status was
Table 3 (Continued )
VA agree Univariate
chi-square
Multivariable logistic
regressionb (n959)
Total n % p OR p
One to two 479 404 84.3
Three to four 255 236 92.5
Five or more 62 61 98.4
HIV status reported pre-mortem to KPS B0.001
Negative 563 515 91.5 0 
Positive 279 232 83.2 0.6 0.03
Unknown 117 12 10.3 0.02 B0.001
Time between death and interview 0.474
Within 6 weeks 675 531 78.7
6 weeks to 6 months 230 183 79.6
612 months 45 39 86.7
Over 12 months 9 6 66.7
aWhere data on HIV status available both from VA and other KPS source, n959.
bMultivariable logistic regression model included only variables with a result here; all variables included in model as continuous variables
except where OR given for each level.
cRecords with missing values were excluded from the analysis concerning that variable.
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high and increased over time to 99%. The increase
coincides with increased HIV testing (including increase
of provider-initiated testing and counselling) and the
rolling-out of ART in the area. Access to ART has been
shown in other settings to normalise HIV and reduce
stigma (22) so may make people more likely to discuss
test results within families or to disclose HIV results to
interviewers.
At 89%, overall agreement on HIV status between the
VA respondent’s report and pre-mortem KPS data sources
was high, implying that, at least in this rural area of
Malawi among those for whom we have a result, data on
HIV status from VAs are reliable enough to be useful
in interpreting VA. However, this must also be interpreted
in the context of only a moderate kappa statistic of 0.5.
Agreement was higher in HIV negatives than positives:
disclosure (to or by the VA respondent) could be more
likely when the result is negative, which has been found in
other settings (15, 16, 23, 24), or the respondent could be
less willing to report the deceased as HIV positive in a VA.
A small number of people (14, 2.5%) were reported to have
HIV/AIDS in the VA but only had records of negative
HIV tests in the KPS data: these are likely to be true
positives that had not yet been captured by KPS, as the
most recent full sero-survey was in 2011.
Agreement on ART usage was also fairly high at 84%
(though the kappa statistic was only moderate at 0.4), and
72% of ART initiation dates matched within 1 year. Some
studies suggest that having started ART was associated
with disclosure (25, 26), due to needing support during
Table 4. Characteristics of deceased according to whether ART usage reported by respondent agrees with other information
known to KPSa
VA agree Univariate
b
chi-square
Multivariable logistic
regressionc (n154)
Total n % p OR p
Total 154 129 83.8
Sex 0.212
Male 81 65 80.2 1
Female 73 64 87.7 2.3 0.154
Age group (years) 0.821 1.2 0.604
1519 4 3 75
2029 17 14 82.4
3044 78 64 82.1
4559 46 39 84.8
6074 7 7 100
75 2 2 100
Year of death 0.765 1.1 0.483
20072008 4 3 75
20092010 56 47 83.9
20112012 52 42 80.8
20132014 42 37 88.1
AIDS symptoms 0.101 0.1 0.004
One or fewer 66 59 89.4
Two or more 88 70 79.5
Total number of HIV tests reported to KPS 0.035 1.6 0.069
None 12 8 66.7
One to two 82 65 79.3
Three to four 43 39 90.7
Five or more 17 17 100
ART usage reported pre-mortem to KPS B0.001 31.3 B0.001
Never started ART 28 13 46.4
Started ART 126 116 92.1
aWhere data on ART usage available both from VA and other KPS source, n154.
bUnivariate analysis for the following variables not shown (all p0.1): place of death, highest schooling, rank of employment, type of
respondent, and time between death and VA.
cMultivariable logistic regression model included only variables with a result here; all variables included in model as continuous variables
except where OR given for each level.
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illness (27) and treatment but others have found the
opposite effect (28). In Malawi it is recommended that
people starting ART have a ‘treatment guardian’ (who
attends the pre-ART counselling with the patient and is
allowed to collect the medication on their behalf if
required) (29), so it is to be expected that agreement
would be high.
Agreement on HIV status was more likely if the
deceased was male. Evidence on the association between
gender and disclosure of HIV status is mixed, with many
studies reporting no association (15, 25, 30, 31) and some
reporting that women are less likely to disclose their
status to anyone (24, 32). Unfortunately, the sex of the
respondent was not recorded in our data.
In our data, increasing number of HIV tests reported
by the deceased to KPS was associated with increased
likelihood of the respondent reporting knowing the HIV
status, as well as agreement on the status and on ART
usage. Repeated voluntary HIV testing has been found to
be associated with greater HIV knowledge, better health
(33), and less risky sexual behaviour (34), which may also
be linked to greater willingness to discuss HIV within the
family.
We did not find any evidence that socio-economic status
had any effect on reporting HIV/ART data in VAs;
however the majority of the population are subsistence
farmers, so there may not have been enough variation in
socio-economic status to see an effect. The relationship
between disclosure to a relative and socio-economic status
is not consistent in the literature. One study in South Africa
found that poorer women were less likely to disclose;
however the opposite effect was seen in men (30). Some
studies found no association between disclosure and
education (25, 26), but others found that increased
education was a predictor of disclosure (31, 35).
There was some evidence that if the respondent was the
parent of the deceased, agreement on HIV status was
more likely than if they were any other type of respondent.
It has been reported that some people find it easier to
disclose to female relatives (27) and that disclosing to the
father is difficult (36) and less common than to the mother
(26). A study in Ethiopia found that people were more
likely to disclose to their partners but not to their children
(35). We could not explore this as our respondent data are
only available by the broad categories shown in Table 1:
partner is combined with child and sibling and age and sex
of the respondent were not collected.
The strength of our study of having a high number of
VAs reporting HIV/ART information and being able to
compare this information to other sources of pre-mortem
data may make our results difficult to generalise to other
settings, as regular sero-surveys and other studies create an
artificial environment where more people know their
status than would usually be the case and people are
more used to taking part in interviews than in other areas.
People who have taken part in more surveys will also have
had more opportunity to report more HIV tests. About
half of the VA records with HIV/ART information
reported did not have any pre-mortem data to compare
to, which made the numbers in some categories quite
small, especially when looking at data on those who
started ART, causing some difficulties in interpreting
some of the results. People with no pre-mortem HIV/
ART information may also have been different to those
with information available, which could have introduced
bias: deaths prior to 2007 (the first full sero-survey) would
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be less likely to have pre-mortem data, and pre-mortem
data after 2011 (the final sero-survey) would come from
smaller studies or ART clinics only, making them more
likely to be HIV positive and seeking care. In addition, we
allowed a person to be HIV negative for up to 3 years after
a report of a negative test; however, they could have tested
positive in that period prior to death so our pre-mortem
data cannot be seen as infallible.
In conclusion, in this population, HIV/ART informa-
tion was often reported during a VA in recent years and
matched relatively well with other sources of data. Asking
about HIV status and ART use is an important and, in
this setting, reliable component of the VA. In other
settings where reporting of HIV/ART information during
a VA may be less common and more associated with
background factors, bias might be introduced in assign-
ing cause of death, which may affect the proportion of
deaths attributed to HIV/AIDS in the community.
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Paper context
Verbal autopsies (VA) are commonly used to assign cause of
death in low-resource settings for surveillance purposes. In
areas affected by the AIDS pandemic, information on the
deceased’s HIV status and ART usage is vital in accurately
assigning cause of death. Medical records are not always
available so the VA-respondent’s report maybe the only
source of information. This paper assesses the reliability of
VA-respondent reports of HIV/ART information in a rural
African setting.
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